The Global Pharmaceuticals Market Strategic Intelligence Suite 2026-2031 is Navadhi Market Research's most comprehensive offering on the global pharmaceutical industry. This suite bundles two full-length strategic research reports -- covering the entire pharmaceutical value chain from manufacturing and production capacity through to end-market consumption and drug spending -- together with an exclusive Executive Presentation, a cross-report Summary Document, and an interactive Infographic.

The Global Pharmaceuticals Industry Strategic Research Report [1] (consumption/demand-side) was valued at $1.66 trillion in 2025 and is projected to reach $2.45 trillion by 2031, a CAGR of 6.8%, with GLP-1 and cardiometabolic franchise expansion the single largest growth contributor, adding an estimated $280 billion of incremental value by 2031. Twenty-five companies are profiled in depth.

The Global Pharmaceuticals Manufacturing Market Strategic Research Report [2] (production/supply-side) was valued at $1.84 trillion in 2025 and is projected to reach $2.86 trillion by 2031, a CAGR of 7.7% -- the fastest sustained production growth rate in the industry's modern history. GLP-1 manufacturing capacity alone is forecast to grow from $45 billion to $180 billion by 2031. Twenty-nine companies are profiled, including 25 integrated innovators and four dedicated CDMOs (Samsung Biologics, Lonza, WuXi Biologics, Catalent).

The single most important finding when viewing both reports together is structural: global pharmaceutical production value consistently exceeds drug market consumption value, and grows at a higher CAGR (7.7% vs. 6.8%). North America consumes 46.8% of global drug spending but produces only 36.7% of global pharmaceutical output -- a structural trade deficit of approximately $90 billion in 2025, widening to approximately $191 billion by 2031. Europe is the largest net exporter, at +$281 billion in 2025, growing to +$528 billion by 2031.

In addition to the two full-length research reports, the suite includes three exclusive deliverables: a 10-slide Executive Presentation providing a cross-report visual summary of key findings and the production-consumption linkage; a Summary Document explaining how the two markets interconnect across the pharmaceutical value chain; and an Interactive Infographic providing a high-impact visual overview of the suite's key data points for executive briefings and stakeholder communication.

Please note: individual reports can also be purchased separately based on your specific data needs.